Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.

Sleeve gastrectomy and gastric bypass were associated with about five-times more weight loss than weekly injections of GLP-1 receptor agonists semaglutide or tirzepatide, at the end of two years, ...

When researchers analyzed weight loss results from patients who took GLP-1 drugs and those who'd undergone bariatric surgery, one method led to much more weight loss.

GLP-1 drugs show promise in diabetes management, offering heart and kidney benefits, but also highlight the need for ...

While GLP-1s have been an effective weight loss tool, the first clinical nutrition study shows they can lead to low protein and essential nutrient intake ...

People who have metabolic and bariatric surgery are significantly less likely to develop psychiatric disorders compared to ...

Popular weight loss drugs such as Wegovy and Zepbound have shown incredible success in clinical trials. But in the real world ...

Individuals with type 2 diabetes who receive treatment with GLP-1 RAs do not have an increased risk for acute pancreatitis.

Real-world cost barriers and insurance denials contribute to early discontinuation of injectable glucagon-like peptide-1 (GLP ...

Glucagon-Like-Peptide-1 Agonists, like Ozempic, have become extremely popular for weight loss. Here are some of the side ...